Before a childhood vaccine reaches a pediatrician’s syringe, it passes through a word. The word is not a dose or a schedule but a label: “routine,” “risk-based,” or the mouthful the CDC adopted in 2019, “shared clinical decision-making.” That label is not bedside jargon. It decides whether your insurer covers the shot without a copay, whether the federal Vaccines for Children program buys it for kids who can’t pay, and whether a state can fold it into a school requirement. Three categories, and the machinery of American immunization sorts itself behind them.
We have seen this before, in medicine and out of it: the machinery that produces a decision ends up mattering as much as the decision, and the public loses track of which is which. The label is supposed to communicate. Often it doesn’t. When researchers surveyed pediatric primary-care providers in 2018, only 24 percent could accurately define the old “Category B” permissive recommendation, the same category that “shared clinical decision-making” was later built to clarify. A majority did not know those vaccines were covered by private insurance or the Vaccines for Children program. The people holding the syringe could not reliably say what the word on the schedule meant.
Renaming it did not fix the confusion. A 2021 national survey of primary-care physicians, this one focused on adult immunization, found that 90 to 95 percent said a shared-decision recommendation took more time to carry out than a routine one, fewer than half knew the vaccine was still covered by insurance, and most said the category confused their patients. Picture what that does at the visit. A parent hears “shared decision” and reasonably infers “optional, and maybe not paid for.” A pediatrician running twenty minutes behind reaches for the shot that carries a clear default and skips the one that comes wrapped in a conversation. A label meant to respect choice suppresses uptake instead, quietly, while looking like deference.
This week the federal government put that machinery up for inspection. In a request for information published on August 24 and signed by Health and Human Services Secretary Robert F. Kennedy Jr., HHS asks whether the three categories that classify every federal vaccine recommendation are still adequate, clear, and trusted, and whether new ones should replace them. Comments are due September 20. One candidate category the notice floats in plain language: “recommended, but not during infancy.”
Read that proposed wording next to the calendar and the intent comes into focus. It is the operational half of the August 10, 2026 executive order, “Delivering Gold Standard Childhood Vaccine Recommendations for Americans,” which directs Kennedy, working through the reinstated Task Force on Safer Childhood Vaccines, to deliver within 90 days a plan on the timing and sequencing of the federal schedule and the continuous re-evaluation of each vaccine’s risk-benefit profile. Build the vocabulary now, and you have the language you need to move a shot off the infant schedule later. This was never only a fight about jargon.
The deeper current running through the notice is trust, and here HHS is unusually candid for a federal filing: it walks straight into the COVID-era record the public-health establishment spent years calling settled. In September 2021, ACIP voted against recommending boosters for healthy adults aged 18 to 64 on the basis of workplace exposure, its members arguing that the call belonged to individual risk judgment. The CDC director set the vote aside and broadened the recommendation anyway, an override so unusual it made national news. The RFI names that episode as a case study in how a top-down reversal of the deliberative process corrodes confidence in the whole system. This is how a bureaucratic vocabulary turns into coercive power: a category built for individual judgment gets quietly overruled from above, and the public is left unable to tell whether a federal recommendation reflects the evidence or the politics.
The notice does not stop at its own agencies. It cites the 2023 New England Journal of Medicine commentary that called the all-ages bivalent booster rollout “a cautionary tale,” and the 2025 NEJM piece from current FDA leadership arguing for a risk-stratified approach in place of blanket recommendations. These are not skeptics shouting from the margins. In several cases they are the same institutions Americans were told to trust without question, now conceding the point on the record.
The filing goes further, assembling the research on what coercion costs. It cites work in the Proceedings of the National Academy of Sciences finding that enforcement can crowd out voluntary cooperation where trust in government is already thin, studies documenting mandate-driven “reactance” that lowered people’s intent to vaccinate, and the World Health Organization’s own 2022 ethics brief warning that mandates are not justified when less coercive means will do. It notes the countervailing studies where mandates did raise uptake, mostly in countries whose baseline trust in government runs higher than ours. The lesson the filing keeps circling, and one this publication has argued for years, is blunt: recommendations that outrun their evidence, and mandates that outrun consent, cost more in credibility than they gain in compliance. Kindergarten vaccination coverage has since slipped below pre-pandemic levels while exemptions have climbed to record highs. The agencies did that to themselves.
None of this arrived from nowhere. In June 2025, Kennedy dismissed all 17 sitting members of ACIP and, days later, named eight replacements, several of whom have long questioned aspects of vaccine safety and policy. Critics reached for the familiar vocabulary within hours: “anti-science,” “captured,” “a takeover.” It is worth asking who is served by treating any reexamination of the schedule as heresy. The committee that produced the overreach this notice now documents was not a neutral body either. It simply carried the presumption of neutrality that comes with sitting in the chairs for a long time. The reformers have a point of view. So did their predecessors. The honest question is whether the recommendations can survive being made to show their evidence in public, with the burden of proof finally resting on the recommendation, not on the parent asking why.
For now, a request for information changes nothing on paper. The notice alters no existing recommendation, no coverage rule, no program, and it says so explicitly. The real test is on the calendar. Watch the docket close on September 20, and watch what the Task Force on Safer Childhood Vaccines hands the President by early November, when the 90-day clock runs out. That plan, not this vocabulary exercise, is where the words stop being words and start deciding which shots a one-year-old gets, and when.
Sources
- Federal Register – HHS Request for Information, “Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making,” Docket HHS-OS-2026-0332 (Aug. 24, 2026)
- The White House – Executive Order, “Delivering Gold Standard Childhood Vaccine Recommendations for Americans” (Aug. 10, 2026)
- CNBC – “The leader of CDC just made a rare call to allow Covid booster shots for more people” (Sept. 23, 2021)
- J Gen Intern Med – Kempe et al., “Shared Clinical Decision-Making Recommendations for Adult Immunization: What Do Physicians Think?” (2021)
- World Health Organization – “COVID-19 and mandatory vaccination: ethical considerations” (2022)
- CNN – “RFK Jr. removes all current members of CDC vaccine advisory committee” (June 9, 2025)
- TrialSite News – “HHS Opens the Vaccine Recommendation Rulebook: Evidence, Autonomy and Trust Move to Center Stage” (2026)